Progress in Genetic Vaccine Against Tumor

Progress in Biochemistry and Biophysics

Volumn 30, Issue 5, 2003, Pages 706-710

  Shi, Shu Qun ^a   Peng, Jing Pian ^a  

^a INSTITUTE OF ZOOLOGY   (China)

Author keywords

Dendritic cells fusion vaccine; Genetic vaccine against tumor; Tumor associated antigens (TAAs)

Indexed keywords

DNA VACCINE; EPITOPE; RNA VACCINE; TUMOR ANTIGEN; TUMOR VACCINE; UNCLASSIFIED DRUG;

ADOPTIVE IMMUNOTHERAPY; CANCER PREVENTION; CELLULAR IMMUNITY; DENDRITIC CELL; FUSION GENE; HUMORAL IMMUNITY; IMMUNOGENICITY; IMMUNOLOGICAL TOLERANCE; REVIEW;

EID: 0346097938     PISSN: 10003282     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (20)

1. Rosenberg S A, Packard B S, Aebersold P M, et al. Use of tumorinfiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. New Engl J Med, 1988, 319 (25): 1670-1680
2. Krieg AM, Yi A K, Schorr J, et al. The role of CpG dinucleotides in innate DNA vaccines. Trends Microbiol, 1998, 6 (1): 23-27
3. Moingeon P. Cancer vaccines. Vaccine, 2001, 19 (11-12): 1305-1326
4. Chen Y, Shi S Q, Yang Y, et al. Prog Biochem Biophys, 2003, 60 (1): 60-66
5. Chen Y, Liu Z, Peng JP, et al. Infertility in mice induced by the rhesus monkey chorionic gonadotropin β-subunit glycoprotein (rmCGβ) using DNA immunization. Mol Cell Biochem, 2002, 213 (1-2): 89-96
6. Wei Y Q, Huang MJ, Li Y, et al. Immunogene therapy of tumors with vaccine based on Xenopus homologous vascular endothelial growth factor as a model antigen. Proc Natl Acad Sci USA, 2001, 98 (20): 11545-11550
7. Wlazlo A P, Ertl H C J. DNA tumor vaccines. Archivum Immunologiae Therapie Experimentalis, 2001, 49 (1): 1-11
8. Wolkers M C, Toebes M, Okabe M, et al. Optimizing the efficacy of epitope-directed DNA vaccination. J Immunol, 2002, 168 (10): 49985-50004
9. Xiang R L, Zhou F, Peng J P. Construction of the plasmid pCMV4-rZPC' DNA vaccine and analysis of its contraceptive potential. Biol Reprod, 2003, 68 (5): 1518-1524
10. Zhu D L, Rice J, Natalia S, et al. DNA fusion vaccines against B-cell tumors. Trends in Molecular Medicine, 2001, 7 (12): 566 -571
11. Hearn J C, Tomoko H, Sandip K, et al. IFN-αβ promote proming of antigen-specific CD8 + and CD4 + T lymphocytes by immunostimulatory DNA-based vaccines. J Immunol, 2002, 168 (10): 4907-4913
12. Howard L K, Ken F, Christopher S D, et al. Insertion of interleukin-2 (IL-2) and interleukin-12 (IL-12) genes into vaccinia virus results in effective anti-tumor responses without toxicity. Vaccine, 2002, 20 (13-14): 1862-1869
13. Hung CF, Hsu K F, Cheng W F, et al. Enhancement of DNA vaccine potency by linhage of antigen gene to a gene encoding the extracellular domain of Fms-like tyrosine kinase 3-ligand. Cancer Res, 2001, 4 (1): 41-48
14. Caley I J, Betts M R, Irlbeck D M, et al. Humoral, mucosal, and cellular immunity in response to a human immunodeficiency virus type 1 immunogen expressed by a Venezuelan equine encephalitis virus vaccine vector. J Virol, 1997, 71 (4): 3031-3038
15. Chang G J, Hunt A R, Davis B. A single intramuscular injection of recombinant plasmid DNA induces protective immunity and prevents Japanese encephalitis in mice. J Virol, 2000, 74 (9): 4244-4252
16. Frolkis M, Fisher M B, Wang Z, et al. Dendritic cells reconstituted with human telomerase gene induce potent cytotoxic T-cell response against different types of tumors. Cancer Gene Ther, 2003, 10 (3): 239-249
17. Zsuzsa V, Amitabha M. Generation of tumor cell lysale-loaded dendritic cells preprogrammed for IL-12 production and augmented T cell response. Cancer Immunol Immunother, 2003, 52 (2): 67-79
18. Kleindienst P, Brocker T. Endogenous dendritic cells are required for amplification of T cell response induced by dendritic cell vaccines in vivo. J Immunol, 2003, 170 (6): 2817-2823
19. Pirtskhalaishvili G, Shurin G V, Esche C , et al. Cytokine-mediated protection of human dendritic cells from prostate cancer-induced apoptosis is regulated by the Bcl-2 family of proteins. Br J Cancer, 2000, 83 (4): 506-513
20. Pirtskhalaishvili G, Shurin G V, Gambotto A, et al. Transduction of dendritic cells with Bcl-xL increases their resistance to prostate cancer-induced apoptosis and antitumor effect in mice. J Immunol, 2000, 165 (4): 1956-1964